180 related articles for article (PubMed ID: 8445949)
1. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
[TBL] [Abstract][Full Text] [Related]
3. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
4. Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells.
Aries A; Trentesaux C; Ottolenghi S; Jardillier JC; Jeannesson P; Doubeikovski A
Blood; 1996 Apr; 87(7):2885-90. PubMed ID: 8639908
[TBL] [Abstract][Full Text] [Related]
5. Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation.
Gillet R; Bobichon H; Trentesaux C
Biol Cell; 2002 Sep; 94(4-5):267-73. PubMed ID: 12489695
[TBL] [Abstract][Full Text] [Related]
6. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
7. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
[TBL] [Abstract][Full Text] [Related]
8. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
Karacay B; Chang LS
Genomics; 1999 Jul; 59(1):6-17. PubMed ID: 10395794
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the transcriptional factor GATA-1 in regulation of expression of coproporphyrinogen oxidase in mouse erythroleukemia cells.
Tanabe A; Furukawa T; Ogawa Y; Yamamoto M; Hayashi N; Tokunaga R; Taketani S
Biochem Biophys Res Commun; 1997 Apr; 233(3):729-36. PubMed ID: 9168923
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
Chang TJ; Scher BM; Waxman S; Scher W
Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
[TBL] [Abstract][Full Text] [Related]
11. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
12. CP2 binding to the promoter is essential for the enhanced transcription of globin genes in erythroid cells.
Chae JH; Kim CG
Mol Cells; 2003 Feb; 15(1):40-7. PubMed ID: 12661759
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
14. 3'-Azido-3'-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells.
Bridges EG; Trentesaux C; Lahlil R; Spiga MG; Jeannesson P; Sommadossi JP
Eur J Haematol; 1996; 56(1-2):62-7. PubMed ID: 8599995
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
Morceau F; Schnekenburger M; Blasius R; Buck I; Dicato M; Diederich M
Cancer Lett; 2006 Aug; 240(2):203-12. PubMed ID: 16274927
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the binding of GATA factors to the regulatory elements of human beta-globin gene in hydroxyurea-induced and uninduced HEL cells].
Zhao H; Zhang SB; Jiang S; Qian RL
Shi Yan Sheng Wu Xue Bao; 1999 Sep; 32(3):243-9. PubMed ID: 12548806
[TBL] [Abstract][Full Text] [Related]
17. [A novel erythroid differentiation related gene EDRF1 upreguated globin gene expression in HEL cells].
Wang D; Shen B; Li Y
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1512-5. PubMed ID: 16200778
[TBL] [Abstract][Full Text] [Related]
18. [Functional analysis of human A gamma-globin gene promoter with-173 T-->C mutation].
Huang X; Zhang J; Yang X; Wang Y; Zhao H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):252-6. PubMed ID: 12567445
[TBL] [Abstract][Full Text] [Related]
19. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
20. Time-course of butyric acid-induced differentiation in human K562 leukemic cell line: rapid increase in gamma-globin, porphobilinogen deaminase and NF-E2 mRNA levels.
Chénais B; Molle I; Trentesaux C; Jeannesson P
Leukemia; 1997 Sep; 11(9):1575-9. PubMed ID: 9305615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
